Results 91 to 100 of about 3,192 (113)

Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. [PDF]

J Clin Oncol
Mateos MV, Martínez-López J, Martínez-López J, Rodriguez Otero P, González-Calle V, Gonzalez MS, Oriol A, Gutiérrez NC, Ríos-Tamayo R, Rosiñol L, Alvarez Rivas MA, Bargay J, Gonzalez-Rodriguez AP, Alegre A, Escalante F, Iñigo Rodríguez MB, De La Rubia J, Teruel AI, de Arriba F, Palomera L, Hernández MT, Lopez Jiménez J, Reinoso-Segura M, García Mateo A, Ocio EM, Paiva B, Puig N, Cedena MT, Bladé J, Lahuerta JJ, San-Miguel JF, Spanish Myeloma Group (GEM-Pethema).   +31 more
europepmc   +1 more source

O TEATRO ANARQUISTA E O CONCEITO DE ARTE NA IMPRENSA OPERÁRIA DE 1901 A 1922

Projeto História, 2012
Eduardo Gramani Hipólide
doaj  

Cross-Cultural Adaptation and Translation of the Neck Dissection Impairment Index (NDII) into Spanish. [PDF]

J Otolaryngol Head Neck Surg
Vargas L, Langlie J, McGee C, Ma R, Perdigon O, Lai SY, Chepeha D, Civantos FJ.   +7 more
europepmc   +1 more source

Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma. [PDF]

Haematologica
Mateos MV, Weisel K, Terpos E, Delimpasi S, Kastritis E, Zamagni E, Delforge M, Ocio E, Katodritou E, Gay F, Larocca A, Leleu X, Otero PR, Schjesvold F, Cavo M, Dimopoulos MA.   +15 more
europepmc   +1 more source

[Association between environmental noise exposure and sleep quality in adults living in Medellín, Colombia, 2022: an exploratory study]. [PDF]

Cad Saude Publica
Rojas-Sánchez OA, Ochoa-Villegas J, Marín D, Piñeros-Jiménez JG, Rodriguez-Villamizar LA.   +4 more
europepmc   +1 more source

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. [PDF]

Int J Mol Sci
Díaz-Tejedor A, Rodríguez-Ubreva J, Ciudad L, Lorenzo-Mohamed M, González-Rodríguez M, Castellanos B, Sotolongo-Ravelo J, San-Segundo L, Corchete LA, González-Méndez L, Martín-Sánchez M, Mateos MV, Ocio EM, Garayoa M, Paíno T.   +14 more
europepmc   +1 more source

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma. [PDF]

Adv Ther
Einsele H, Moreau P, Bahlis N, Bhutani M, Vincent L, Karlin L, Perrot A, Goldschmidt H, van de Donk NWCJ, Ocio EM, Martinez-Lopez J, Rodríguez-Otero P, Dytfeld D, Diels J, Strulev V, Haddad I, Renaud T, Ammann E, Cabrieto J, Perualila N, Gan R, Zhang Y, Parekh T, Albrecht C, Weisel K, Mateos MV.   +25 more
europepmc   +1 more source

Daratumumab Versus Control Treatment: A Systematic Review and Meta-analysis Study of Survival Outcomes Among Multiple Myeloma Patients : Survival Outcomes of Multiple Myeloma Treatment with Daratumumab. [PDF]

Galen Med J
Salajegheh P, Salajegheh A, Yazdi Yahyaabadi F, Yazdi F.   +3 more
europepmc   +1 more source